Siegel ER - Search Results

1

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.

Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A. Tassi RA, et al. Among authors: siegel er. J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y. J Exp Clin Cancer Res. 2017. PMID: 28482906 Free PMC article.

2

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

Santin AD, Zhan F, Bignotti E, Siegel ER, Cané S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Among authors: siegel er. Virology. 2005 Jan 20;331(2):269-91. doi: 10.1016/j.virol.2004.09.045. Virology. 2005. PMID: 15629771 Free article.

3

Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.

Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M. Kaushal V, et al. Among authors: siegel er. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):584-93. Clin Cancer Res. 2005. PMID: 15701844

4

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, Kay HH, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Among authors: siegel er. Am J Obstet Gynecol. 2005 Mar;192(3):813-8. doi: 10.1016/j.ajog.2004.10.605. Am J Obstet Gynecol. 2005. PMID: 15746676

5

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, Roman JJ, Burnett A, Cannon MJ, Pecorelli S. Santin AD, et al. Among authors: siegel er. Cancer Res. 2005 May 15;65(10):4334-42. doi: 10.1158/0008-5472.CAN-04-3472. Cancer Res. 2005. PMID: 15899825 Free article.

6

Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.

Santin AD, Bellone S, Van Stedum S, Bushen W, Palmieri M, Siegel ER, De Las Casas LE, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Among authors: siegel er. Cancer. 2005 Oct 1;104(7):1391-7. doi: 10.1002/cncr.21308. Cancer. 2005. PMID: 16116605 Free article.

7

PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.

Mayes DA, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung WK, Zhou YH. Mayes DA, et al. Cancer Res. 2006 Oct 15;66(20):9809-17. doi: 10.1158/0008-5472.CAN-05-3877. Cancer Res. 2006. PMID: 17047041

8

Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).

Santin AD, Bellone S, Marizzoni M, Palmieri M, Siegel ER, McKenney JK, Hennings L, Comper F, Bandiera E, Pecorelli S. Santin AD, et al. Among authors: siegel er. Cancer. 2007 Apr 1;109(7):1312-22. doi: 10.1002/cncr.22536. Cancer. 2007. PMID: 17326053 Free article.

9

Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.

Santin AD, Bellone S, Siegel ER, McKenney JK, Thomas M, Roman JJ, Burnett A, Tognon G, Bandiera E, Pecorelli S. Santin AD, et al. Among authors: siegel er. Clin Cancer Res. 2007 Jun 1;13(11):3339-46. doi: 10.1158/1078-0432.CCR-06-3037. Clin Cancer Res. 2007. PMID: 17545541 Free article.

10

Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.

Santin AD, Bellone S, Palmieri M, Zanolini A, Ravaggi A, Siegel ER, Roman JJ, Pecorelli S, Cannon MJ. Santin AD, et al. Among authors: siegel er. J Virol. 2008 Feb;82(4):1968-79. doi: 10.1128/JVI.02343-07. Epub 2007 Dec 5. J Virol. 2008. PMID: 18057249 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters